Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could hepatitis b donor lungs save more lives? new safety trial begins

NCT ID NCT07189377

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 29 times

Summary

This study tests whether lungs from donors with hepatitis B can be safely transplanted into people who do not have the virus. The lungs are treated with a special machine (EVLP) and UV light to kill the virus, and recipients take antiviral drugs. The goal is to see if this approach prevents infection in the 20 participants over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B VIRUS (HBV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Health Network, Toronto General Hospital

    RECRUITING

    Toronto, Ontario, M5G 2C4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.